Oral antidiabetic agents

Clifford J. Bailey*, Andrew J. Krentz

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish
Title of host publicationTextbook of diabetes
EditorsRichard I.G. Holt, Clive S. Cockram, Allan Flyvbjerg, Barry J. Goldstein
Number of pages26
ISBN (Electronic)978-1-4443-2480-8
ISBN (Print)978-1-4051-9181-4
Publication statusPublished - 9 Jul 2010


  • α-Glucosidase inhibitors
  • Action to Control Cardiovascular Risk in Diabetes (ACCORD)
  • antiobesity therapies
  • fixed-dose combinations
  • guidelines and algorithms
  • maturity-onset diabetes of the young (MODY)
  • meglitinides
  • pathophysiologic considerations
  • peroxisome proliferator-activated receptor (PPAR)
  • UK Prospective Diabetes Study (UKPDS)
  • short-acting prandial insulin releasers

Research Output

Future drug treatments for type 2 diabetes

Bailey, C. J., 9 Jul 2010, Textbook of diabetes. Holt, R. I. G., Cockram, C. S., Flyvbjerg, A. & Goldstein, B. J. (eds.). 4th ed. Wiley-Blackwell, p. 1017-1044 28 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cite this

Bailey, C. J., & Krentz, A. J. (2010). Oral antidiabetic agents. In R. I. G. Holt, C. S. Cockram, A. Flyvbjerg, & B. J. Goldstein (Eds.), Textbook of diabetes (4th ed., pp. 452-477). Wiley-Blackwell. https://doi.org/10.1002/9781444324808.ch29